Mark Ginsburg
Pediatrics · Miami, FLNPI 1508869629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$251
- Cranial Technologies, Inc$174
- Pfizer$160
- Verrica Pharmaceuticals Inc.$122
- GSK$110
- Ironshore Pharmaceuticals Inc.$97
- plus $599 from 16 others
Across 33 payments — averaging $2337.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$48K
- Pfizer$30K
What the payments were for
- Food & beverage$1,513100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $251 |
| Cranial Technologies, Inc | 9 | $174 |
| Pfizer | 9 | $160 |
| Verrica Pharmaceuticals Inc. | 1 | $122 |
| GSK | 7 | $110 |
| Ironshore Pharmaceuticals Inc. | 5 | $97 |
| Corium, LLC | 5 | $84 |
| Sanofi Pasteur Inc. | 4 | $83 |
| AstraZeneca | 2 | $54 |
| Genentech USA, Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Tris Pharma Inc | 3 | $44 |
| Seqirus USA Inc | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Phadia US Inc. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $29 |
| Meridian Bioscience Inc. | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Kaleo, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YCANTH$122
How this compares
$1,513 in reported general payments places this provider in the 90th percentile of 3,964 pediatrics providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 11 | $6,147 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Miami
- Patricia DeanMiami$92K
- Sofia MirandaMiami$67K
- Jose HerreraMiami$61K
- Joanna DavisMiami$59K
- Andrew ColinMiami$32K
- Luis BlancoMiami$13K
- Annette CaraviaMiami$9K
- Daneb GonzalezMiami$8K
- Aileen RodriguezMiami$7K
- Johana MayorMiami$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.